Learn more

DPHARM LTD

Overview
  • Total Patents
    125
  • GoodIP Patent Rank
    224,902
About

DPHARM LTD has a total of 125 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Israel, United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are OXYPLUS INC, ANACOR PHARMACEUTICALS INC and AMEDIS PHARM LTD.

Patent filings per year

Chart showing DPHARM LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kozak Alexander 77
#2 Shapiro Israel 42
#3 Vinnikova Marina 23
#4 Reznitsky-Cohen Dalia 14
#5 Senderikhin Alexander 12
#6 Vinikova Marina 10
#7 Beit-Yannai Eliezer 8
#8 Polyak Michael 8
#9 Ershov Leonid 7
#10 Ayalon Oran 7

Latest patents

Publication Filing date Title
WO2015092789A1 Onium salts of lipophilic diesters of chelating agents
WO2015092788A1 Compositions comprising lipophilic diesters of chelating agents non-covalently associated with organic amines
WO2011086561A1 Process for the preparation of 3-(1-cyclopropenyl) propionic acid and its salts
US2011105607A1 Lipophilic diesters of chelating agent for inhibition of enzyme activity
IL203400A Peptides derived from plasminogen activator inhibitor-1 and uses thereof
CN101808655A Peptides derived from plasminogen activator inhibitor-1 and uses thereof
IL159241A Use of branched-chain fatty acids and derivatives thereof in the manufacture of a medicament for the treatment of pain
IL157396D0 Use of lipophilic diesters of chelating agent for the treatment of amyloidosis and atherosclerosis
IL157397D0 Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy
US2006167092A1 Lipophilic diesters of chelating agent for inhibition of enzyme activity
AU2003213856A1 Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy
IL154245D0 Covalent conjugates of drugs with branched-chain lipid-mimetic molecules
IL153147A Pharmaceutical compositions comprising phospholipid conjugates of valproic acid or derivatives thereof
US7582678B2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
IL147993D0 Covalent conjugates of drugs with branched-chain lipid-mimetic molecules
IL154246D0 Derivatives of branched-chain lipophilic molecules and uses thereof
US2002042445A1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
US6605638B1 Use of branched chain fatty acids and derivatives thereof for inhibition of P-glycoprotein
IL148554D0 Phospholipid prodrugs of anti-proliferative drugs
IL137672D0 Derivatives of branched-chain lipophilic molecules and uses thereof